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ABSTRACT
In order to understand the role of microRNAs (miRNAs) in vascular physiopathology, we took advantage of deep-sequencing
techniques to accurately and comprehensively profile the entire miRNA population expressed by endothelial cells exposed to
hypoxia. SOLiD sequencing of small RNAs derived from human umbilical vein endothelial cells (HUVECs) exposed to 1% O2 or
normoxia for 24 h yielded more than 22 million reads per library. A customized bioinformatic pipeline identified more than 400
annotated microRNA/microRNA* species with a broad abundance range: miR-21 and miR-126 totaled almost 40% of all
miRNAs. A complex repertoire of isomiRs was found, displaying also 59 variations, potentially affecting target recognition. High-
stringency bioinformatic analysis identified microRNA candidates, whose predicted pre-miRNAs folded into a stable hairpin.
Validation of a subset by qPCR identified 18 high-confidence novel miRNAs as detectable in independent HUVEC cultures and
associated to the RISC complex. The expression of two novel miRNAs was significantly down-modulated by hypoxia, while miR-
210 was significantly induced. Gene ontology analysis of their predicted targets revealed a significant association to hypoxia-
inducible factor signaling, cardiovascular diseases, and cancer. Overexpression of the novel miRNAs in hypoxic endothelial cells
affected cell growth and confirmed the biological relevance of their down-modulation. In conclusion, deep-sequencing
accurately profiled known, variant, and novel microRNAs expressed by endothelial cells in normoxia and hypoxia.
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INTRODUCTION
MicroRNAs (miRNAs) are endogenous, short, 21- to
23-nucleotide (nt), nonprotein-coding RNAs that act as neg-
ative regulators of gene expression, modulating the trans-
lational efficiency and/or the stability of target messenger
RNAs (mRNAs). These RNA molecules are transcribed as
a long primary transcript, termed pri-miRNA, sequentially
processed by Drosha and Dicer ribonucleases, first to a pre-
cursor-miRNA with a characteristic hairpin structure and
then to the mature miRNA species. Then, the single-stranded,
mature miRNA is loaded together with Argonaute (Ago)
proteins into the RNA-induced silencing complex (RISC),
a ribonucleoprotein complex mediating post-transcriptional
gene silencing. Sequence-specific interaction with the func-
tional miRNA leads to destabilization or translational in-
hibition of the target mRNAs by the Ago protein (Winter et al.
2009). For several pre-miRNAs, both hairpin arms are
processed and give rise to a functional miRNA. In this case,
mature miRNAs are designated with the suffix ‘‘-3p’’ or ‘‘-5p,’’
depending on the originating hairpin arm. Alternatively, if
either one is expressed at much lower levels, it is designated as
miRNA* (star form) (Winter et al. 2009; Krol et al. 2010).
MiRNAs have essential functions in physiological pro-
cesses, including cellular differentiation, development, and
apoptosis, but are also involved in pathological processes,
like cancer (Garzon et al. 2009; McCormick et al. 2010) or
cardiovascular diseases (Urbich et al. 2008; Dorn 2010;
Fasanaro et al. 2010).
Hypoxia describes the insufficient oxygen supply to tissues
and occurs during several physiopathological circumstances
such as rapid tissue growth, acute and chronic ischemia,
6These authors contributed equally to this work.
7Corresponding author.
E-mail f.martelli@idi.it.
Article published online ahead of print. Article and publication date are
at http://www.rnajournal.org/cgi/doi/10.1261/rna.027615.111.
472 RNA (2012), 18:472–484. Published by Cold Spring Harbor Laboratory Press.
 Cold Spring Harbor Laboratory Press on December 9, 2015 - Published by rnajournal.cshlp.orgDownloaded from 
organ and tumor development, and high altitude (Semenza
2010b). Decreased oxygen tension triggers a distinct pro-
gram of responses aimed at relieving tissue hypoxia and
removing irreversibly damaged cells. These responses include
endothelial cell proliferation, migration, and angiogenesis
and also growth arrest and apoptotic cell death (Semenza
2010b). Several reports have demonstrated that specific
miRNAs are involved in the hypoxic response (Ivan et al.
2008). In particular, we and others found that the
expression of miR-210 is induced in hypoxic endothelial
cells (Fasanaro et al. 2008; Chan et al. 2009), stimulating
their vascular endothelial growth factor (VEGF)–driven
migration and tubulogenesis (Fasanaro et al. 2008).
In order to understand how miRNAs regulate gene
expression in endothelial cells exposed to low-oxygen
tension, it is essential to accurately profile the entire miRNA
population. Currently, there are three widely used platforms
for miRNA profiling: quantitative polymerase chain reac-
tion (qPCR), microarray hybridization (Shendure 2008), and
deep-sequencing (also named next-generation sequencing
or massively parallel sequencing). While qPCR and micro-
arrays rely on the availability of miRNA sequences in public
and proprietary databases for designing probes or primers
(Griffiths-Jones et al. 2008), deep-sequencing offers the pos-
sibility to comprehensively assess miRNA expression in a
timely and cost-effective fashion. Along with unprecedented
scale and linear range, the sequencing approach does not have
thermodynamic biases usually associated with hybridization-
based qPCR andmicroarray platforms (Shendure 2008).More-
over, deep-sequencing allows discovery of previously unchar-
acterized miRNA species. These include not only new miRNAs
that eluded previous cloning but also a panoply of miRNA
variants, also known as isomiRs (Landgraf et al. 2007; Morin
et al. 2008; Fernandez-Valverde et al. 2010).
In this study the power of deep-sequencing technology
was adopted to determine the complete repertoire of miRNAs
expressed by human endothelial cells and to identify their
modulations induced by low-oxygen tension.
RESULTS
Small RNA library generation, sequencing,
and primary analysis
Human umbilical vein endothelial cells (HUVECs) were
cultured either in normoxic conditions or at 1% oxygen for
24 h. Then, small RNA libraries were prepared and deep-
sequenced by using a SOLiD3 Plus Sequencer platform. As
customary for these kinds of studies, two independent
populations were analyzed, each both in normoxia and in
hypoxia. The corresponding four cDNA libraries yielded a
total of 114 million sequenced reads, and 78% (89 million,
an average of 22.2 million per library) of these reads passed
the quality control filter (quality value [QV] $ 9). Reads
mapping across genomic sequence by >25 nt were removed
owing to the low probability of being miRNA derived. Then,
all remaining reads were trimmed to 25 nt, the maximum
expected length for a miRNA (Winter et al. 2009; Krol et al.
2010), and used for mapping against various coding and
noncoding transcript and genomic data sets.
Identification and quantification of annotated
miRNAs
The customized analysis pipeline represented in Figure 1
was used to quantify previously known (annotated) miRNAs.
The reads corresponding to annotated miRNAs were iden-
tified by selecting all the reads mapping against the
human sequences contained in miRBase v14.0, excluding
any read mapping also against a collection of other small
RNAs databases (transfer RNAs [tRNAs], small nucleolar
RNAs [snoRNAs], ribosomal RNAs [rRNAs]). Then, fur-
ther selection criteria based on alignment length, absence of
mismatches in the seed region, and absence of sequencing
errors were applied: An average of 1.2 million reads per
library were identified as annotated miRNAs, representing
305 mature and 96 miRNA* species. As expected, a very
significant correlation between the results obtained analyzing
the two normoxic and the two hypoxic libraries was observed
(Supplemental Fig. S1). The counts per miRNA were then
normalized with respect to the total library size, and all
FIGURE 1. Analysis pipeline of annotated miRNAs. Flowchart de-
scribing data analysis pipeline designed for the identification of
mature and star sequences of annotated miRNAs, their isoforms,
and novel miRNA star sequences. The number of remaining reads/
hits/miRNAs after each filtering step, averaged across all four libraries,
is indicated in italics. The high-stringency filter of alignment (step 5)
consisted in minimum alignment length of 17 nt, with a maximum of
one mismatch and three sequencing errors. Reads with sequencing
errors in the first 15 nt or mismatches in the seed region were excluded.
microRNA sequencing of hypoxic endothelial cells
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species with percentage counts above 0.001% in both
normoxic libraries (244 miRNAs and 71 miRNA*s) were
investigated further (see Supplemental Table S1). Large
differences in expression levels were observed: 32% of all
identified miRNA sequences belonged to miR-21, while 7%
belonged to miR-126 (Fig. 2A,B; Supplemental Table S1).
Then, deep-sequencing data were compared to the HUVEC
expression profiles we obtained by qPCR (Fasanaro et al. 2008)
and microarray (C Voellenkle, J van Rooij, and F Martelli,
unpubl.) in independent experimental settings. A highly sig-
nificant correlation was observed between deep-sequencing
and qPCR data (see Fig. 2A). A lower, albeit still highly sig-
nificant, level of correlation was observed between the
deep-sequencing and microarray data. Intriguingly, highly
abundant miR-21 and miR-126 were associated with fluo-
rescence levels lower than expected, possibly due to a lower
dynamic range of microarray analysis compared with deep-
sequencing (see Fig. 2B).
Finally, normoxic and hypoxic HUVEC samples were
compared (Fig. 3). As expected, the majority of the miRNA
species displayed no significant differences (Audic and
Claverie test) (Audic and Claverie 1997). However, in
accordance with previous observations (Fasanaro et al.
2008, 2009; Chan et al. 2009), miR-210 was significantly
induced more than eightfold, further validating our deep-
sequencing analysis.
Alternative duplex strand selection of annotated
miRNA/miRNA* pairs
During typical miRNA biogenesis, one strand of the z22-nt
RNA duplex is preferentially selected for entry into a silenc-
ing complex, whereas the other strand of the hairpin, known
as the passenger strand or miRNA* strand, is generally
degraded (Winter et al. 2009; Krol et al. 2010). However,
several studies demonstrate that this preference in hairpin
strand selection can vary in a tissue-specific manner (Ro
et al. 2007; Chiang et al. 2010). Thus, the ratios between
expression levels of annotated mature miRNAs and their
miRNA* siblings were determined. Indeed, for three different
miRNA species, a clear bias toward the miRNA* sequence
was observed, showing more than five times higher expres-
sion compared with the relevant mature sequence (Supple-
mental Fig. S2). These observations suggest that in endothelial
cells, there may be a preferred selection of the passenger
strand for the miRNA/miRNA* pairs of miR-33a, miR-
214, and miR-616.
Identification of novel miRNA* species
Increasing evidence indicates that miRNAs* have a wide-
spread regulatory activity in vertebrates (Mah et al. 2010).
To identify novel miRNA* species, we investigated all
miRNA stem–loops that harbored reads from both arms
but had only one arm already annotated in miRBase.
Reads mapping to an unannotated arm were accepted as
novel miRNA* species only if their counts reached the
abundance of 0.001%, showed >50% complementarity to
the annotated mature species, and showed an overhang
of no more than 3 nt on either the 39 or 59 arm, compared
with the annotated mature sequence. The application of
these stringent selection criteria resulted in the discovery of
nine novel miRNA* species, none of which was annotated in
FIGURE 2. Similar miRNA expression profiles of normoxic HUVECs
obtained with independent techniques. (A) Average Ct of 114 miRNA
species detected by qPCR (n = 4) were compared with the read
counts, expressed in a Log10 scale, obtained by deep-sequencing
(Pearson’s r = 0.86, P < 0.0001). The circles highlight miR-21 and
miR-126, the two most abundant miRNAs among all identified
species in HUVECs. (B) Average Log10-transformed Hy3 intensities
of 269 miRNA probes of miRCURY LNAmicroRNA Arrays version
11.0, Exiqon (n = 7), were compared to the Log10-transformed read
counts obtained by deep-sequencing (Spearman r = 0.64, P < 0.0001).
The circles highlight miR-21 and miR-126.
FIGURE 3. Expression levels of annotated miRNAs in HUVECs
exposed to hypoxic and normoxic conditions. Average Log10-trans-
formed read counts obtained by deep-sequencing of normoxic versus
hypoxic HUVECs. The circle highlights hypoxia-induced miR-210.
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miRBase version 18.0. It is noteworthy that with the ex-
ception of novel miR-216* (/miR-216-3p), these sequences
were also found by others and are displayed in the deep-
sequencing data view of miRBase (Supplemental Fig. S3).
Mature miRNA variants
Mature sequence variants (isomiRs) (Landgraf et al. 2007)
were analyzed, and reads aligning to annotated miRNA
species displaying an occurrence of editing events, single
nucleotide polymorphisms (SNPs), and variations in length
were further investigated. In total, 3153 different isomiRs
with abundance of at least 0.001%, representing 230 different
miRNA and miRNA* species, were identified. Roughly 45%
of the reads aligned precisely to the annotated mature
sequences. The characteristics of the identified isomiRs are
summarized in Supplemental Table S2. We found that the
most common isomiR species were represented by sequence
length variations, at either the 59 (Supplemental Fig. S4A) or
39 end (Supplemental Fig. S4B). Interestingly, for 33 miRNA
species, the most abundant form did not correspond to the
annotated sequence in miRBase (Supplemental Fig. S5A,B).
Further investigation of the deep-sequencing data of miRBase
revealed that for 16 miRNAs, the same isomiR variation was
identified as the highest expressed sequence also by others
(Supplemental Fig. S5A). For the remaining 17, the most
abundant sequence shown in the deep-sequencing data was
either the annotated sequence or a different isomiR variation
(Supplemental Fig. S5B).
Within these 33 miRNAs, the most observed variations
were single-base mutations in the tail (nucleotides 10–20)
or small (1- to 2-nt) 39 additions or deletions. However, 5-nt
or even 6-nt deletions were not uncommon. Occasionally
we identified sequence variants corresponding to no anno-
tated SNP and A-to-G transitions, potentially attributable
to adenosine-to-inosine editing events when the SOLiD
platform is used (Schulte et al. 2010).
Discovery of novel miRNAs
To identify novel miRNAs, we devised an analysis pipeline
even more stringent than the one used to analyze annotated
miRNAs (Fig. 4). Quality filtered reads of all four libraries
were mapped against the human genome (UCSC, assembly
hg19), resulting in about 140 million hits to the genome per
library. We found that many reads did not align to pre-
viously annotated RNAs such as miRBase miRNAs, coding
and noncoding mRNAs, transfer RNAs, ribosomal RNAs,
and other small RNAs (e.g., small nuclear RNAs, Piwi-
interacting RNAs [piRNAs], small nucleolar RNAs), in-
dicating that many small RNAs remain to be discovered
(Supplemental Fig. S6; Yang et al. 2010). To identify novel
miRNAs among these hits, we applied a series of tight
selection criteria, aimed at minimizing the number of false
discoveries: Hit number was reduced by applying a high-
stringency quality filter (23.6 million), requiring a minimum
alignment of 19 nt and allowing only one mismatch and one
sequencing error. Then, we removed reads already annotated
in miRBase and other ncRNA databases (19.9 million) and
all reads mapping to repetitive sequences (14.1 million).
We also speculated that sequencing artifacts and random
Drosha/Dicer processing products may yield less abundant
hits. Thus, we introduced an abundance filter, accepting only
genomic locations harboring 100 or more alignments with
an identical 59 end start (6.6 million hits). One prominent
feature of miRNAs is their biogenesis from a RNA hairpin
structure (Winter et al. 2009; Krol et al. 2010). Thus, we
intersected the remaining hits with a predicted short RNA
hairpin database. We found that more than 270,000 counts,
representing 511 genomic locations, mapped in the stem
(but not in the loop) of one of the predicted hairpins
(Supplemental Table S3).
In order to validate our analysis criteria, reads corre-
sponding to the mature miRNA species identified with the
miRBase mapping were passed through the same pipeline.
Interestingly, in spite of the higher stringency and the
increased abundance threshold, we found that 126 anno-
tated miRNAs were identified (data not shown).
The 511 miRNA candidates were further examined, and
remapping against fRNAdb and miRBase version 18.0
FIGURE 4. Pipeline of genome mapping. Flowchart describing data
analysis pipeline designed for the identification of novel potential miRNA
candidates. Numbers in italics indicate the amount of remaining reads/
hits/miRNAs after each filtering step, averaged across all four libraries.
Filtering threshold for alignment length was set at $19 nt, allowing not
more than one mismatch and one sequencing error. After final overlap
with a hairpin prediction database, more than 270,000 hits remained,
representing 511 candidates for putative novel miRNA locations.
microRNA sequencing of hypoxic endothelial cells
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confirmed that none of the selected sequences were pre-
viously annotated as small noncoding RNA. This candidate
miRNAs data set was considered as a subset of expressed
RNAs potentially enriched for novel miRNAs species. To
confirm this interpretation, 28 of the newly identified
candidate miRNAs were randomly chosen for further
experimental validation.
Novel miRNAs are associated to the RISC
In order to validate the candidate miRNAs, qPCR assays
were developed. We found that 23 out of 28 miRNA
candidates tested were readily detectable in both HUVECs
and HEK-293 cells. However, a caveat applied to novel-
735 since its sequence was similar to that of hsa-miR-151,
and the adopted assay may not discriminate between these
two miRNAs.
In keeping with qPCR data, the expression of novel-181
and novel-1322 was also confirmed by Northern blotting
(Supplemental Fig. S7).
One prominent biological feature of miRNAs is their
association to the RISC effector complex (Winter et al. 2009;
Krol et al. 2010). To assay whether the candidates miRNAs
identified as expressed in HUVECs were associated to the
RISC, we tested if they were detectable in immunoprecip-
itates of Ago2, a crucial RISC component. HEK-293 cells
were transfected with an expression vector for a c-Myc–
tagged allele of Ago2, resulting in cells enriched with c-Myc-
Ago2–containing RISCs. Then, cell lysates were derived and
immunopreciptated using an antibody against c-Myc. The
levels of coimmunoprecipitated miRNAs were measured by
qPCR and compared with the background control, repre-
sented by c-Myc immunoprecipitates derived from back-
bone vector transfected cells. Figure 5, A and B, shows that
18 out of 22 candidate miRNAs displayed a more than
20-fold enrichment in RISCs and were thereby confirmed
as genuine novel miRNAs. Two annotated miRNAs adopted
as positive controls, miR-150 and miR-210, displayed similar
enrichment levels. Predicted hairpin folding of the novel
miRNAs is shown in Figure 5C and Supplemental Figure S8.
Novel-112 and novel-144 miRNAs are
down-modulated by hypoxia
We assayed whether experimentally validated novel miRNAs
were modulated by hypoxia. Given the low numerosity of
the samples analyzed by deep-sequencing, we considered
for further validation only those miRNAs displaying a min-
imum fold change of three and a P-value <0.005 in at least
one of the two sequencing data sets. As shown in Figure 6,
qPCR experiments confirmed that novel-112 and novel-144
were significantly down-modulated in HUVECs exposed to
both 1% and 2% oxygen for 24 h. Furthermore, qPCR mea-
surements showed that novel-112 and novel-144 down-
modulation was maintained when 1% oxygen exposure
was extended to 48 h (Supplemental Fig. S9). As expected,
miR-210 was induced at both time-points and under both
hypoxic conditions (Fig. 6; Supplemental Fig. S9; Fasanaro
et al. 2008, 2009; Chan et al. 2009).
Target prediction and pathway analysis
To investigate the biological relevance of the miRNAs
significantly modulated by hypoxia in HUVECs, functional
FIGURE 5. Novel miRNAs are associated to RISCs. (A) Newly
identified miRNAs were measured in Myc-Ago2–containing RISC
immunocomplexes, and their levels are expressed as average fold change
compared with control (n = 3). Red and green colors indicate up- and
down-regulation, respectively, and modulations are indicated using a
log2 scale (DDCt). (B) Table showing the same values displayed in A
in a linear scale. Candidates highlighted in the red square display
a statistically significant, greater than 20-fold enrichment. (C) Secondary
structures, predicted using RNAfold software (Vienna RNA package), of
three representative novel miRNA stem–loops and of one annotated
miRNA (miR-210). Mature miRNAs are highlighted in red.
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pathway analysis (IPA) was performed of the target genes
predicted for novel-112, novel-144, and miR-210. To this
aim, TargetScan and DIANA–microT algorithms were used,
which allow target prediction of nonpreviously annotated
miRNAs. Experimentally confirmed miR-210 targets were
also used (Devlin et al. 2011). Intriguingly, predicted targets
of hypoxia-modulated miRNAs were significantly associated
to both cardiovascular and neoplastic diseases and, more
specifically, to hypoxia-inducible factor signaling (Fig. 7).
We also searched novel-112, novel-144, and miR-210
predicted targets among hypoxia-modulated genes. We
found that novel-112, novel-144 and miR-210 predicted
targets displayed a fivefold enrichment (P < 0.00001) in
HUVECs exposed to hypoxia conditions identical to these
adopted in our study.
Novel-112 and novel-144 miRNAs affect endothelial
cell growth in hypoxia
To gain further insight into the biological function of
hypoxia-repressed miRNAs, HUVECs were transfected with
mimics of novel-112 and novel-144 or with a negative control
sequence and were exposed to 1% oxygen for 24 and 48 h.
As assessed by growth curves, hypoxia inhibited HUVEC
proliferation, as expected. The overexpression of the two
novel miRNAs had a significant impact on hypoxic cells:
novel-112 and novel-144 overexpression resulted in lower and
higher cell numbers, respectively, compared with scramble
controls (Fig. 8).
DISCUSSION
Deep-sequencing is a powerful technique, allowing not only
absolute quantification of millions of sequences in an un-
biased manner but also the identification of novel miRNAs.
In the present study, the deep-sequencing approach was used
to delineate the complete repertoire of miRNA species
expressed in endothelial cells and to identify miRNA mod-
ulations upon exposure to hypoxic stress.
Very stringent filtering steps were introduced in the
custom-designed pipelines, preferring the loss of possibly
interesting sequences over contamination with false pos-
itives. Thus, the fraction of annotated miRNAs among the
sequenced small RNAs was lower than that reported by
others (Kawaji et al. 2008). For the identification of novel
miRNAs, exclusion criteria were even tighter: along with
very stringent alignment quality cutoffs, sequences mapping
to other small noncoding RNAs, like snoRNAs, rRNAs, and
tRNAs, were also excluded from the analysis. While this
avoided the contamination of random fragments, it may
also lead to the exclusion of genuine miRNA species. Indeed,
very recent studies identified snoRNA-derived molecules
with miRNA-like functions (Ender et al. 2008; Brameier
et al. 2011; Ono et al. 2011).
The expression levels of annotated miRNA measured by
deep-sequencing were similar to those previously obtained
by our group with independent profiling techniques, i.e.,
qPCR and microarrays (Fasanaro et al. 2008). Albeit the
analyzed HUVEC populations were not the same, a high
FIGURE 6. Differential miRNA expression upon hypoxia. Levels of
novel-112, novel-144, and hsa-miR-210 were measured by qPCR in
HUVECs exposed to 1% or 2% oxygen for 24 h. At both oxygen con-
centrations, novel-112 and novel-144 miRNAs were down-modulated
and miR-210 was induced (n = 7; *P < 0.05; **P < 0.001; ***P < 0.001).
FIGURE 7. Ingenuity pathway analysis (IPA) of targets predicted for
miRNAs modulated in HUVECs upon hypoxia exposure. (A) Top
network functions significantly associated to targets predicted for
novel-112, novel-144, and miR-210. Bars, scores computed by IPA. (B)
Pathways and biological functions significantly associated to targets
predicted for novel-112, novel-144, and miR-210. Bars, P-values
evaluated by exact Fisher test expressed in logarithmic scale. Threshold
indicates the minimally accepted significance level of P < 0.05.
Numbers beside the bars indicate number of predicted targets involved
significantly in the indicated pathways.
microRNA sequencing of hypoxic endothelial cells
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correlation degree was found between the read counts and
both Ct or fluorescence intensity. We also found that a small
number of miRNA species largely dominated the miRNA
population: 32% of all annotated miRNAs detectable in
HUVECs were represented by miR-21; 7%, by miR-126.
However, much less abundant miRNAs, such as miR-210
(<0.02% of the miRNA population in normoxia), also have
a proven biological role in endothelial cells (Fasanaro et al.
2008; Chan et al. 2009). The biological significance of these
wide abundance differences is currently unknown but may
relate to the abundance of the corresponding target mRNAs
(Bartel 2009; Matkovich et al. 2010). Investigation of differ-
ential expression among annotated miRNAs by deep-seq-
uencing analysis revealed the expected significant induc-
tion of miR-210 in both libraries. Two other miRNAs,
miR-150 and miR-328, that we previously identified as
significantly up-regulated by hypoxia in endothelial cells
(Fasanaro et al. 2008) were significantly induced only in
one of the two libraries. This might be due to the slow
kinetics of their up-modulation, which reach a more than
fivefold induction only after 48 h exposure to hypoxic
conditions (Fasanaro et al. 2008).
Deep-sequencing analysis also allowed appreciation of
the high degree of variability of miRNAs (Landgraf et al.
2007). Indeed, the occurrence of editing events or the
presence of unknown variations in sequence length are
not quantified with traditional profiling platforms and
might interfere with the precision of differential expres-
sion analysis, especially when looped reverse transcrip-
tion primers are used (Benes and Castoldi 2010).
Differences in sequence length are likely due to variabil-
ity in either Dicer1 or Drosha cleavage positions (Morin
et al. 2008; Wu et al. 2009), whereas single base changes can
be attributed to SNPs or editing events, reported as frequently
occurring in miRNAs (Kawahara et al. 2007; Landgraf et al.
2007; Morin et al. 2008; Dupuis and Maas 2010; Marti et al.
2010). We cannot exclude that differences in sequence length
could be due to aspecific degradation, but we would expect
these events to affect all miRNA species equally. Conversely,
we found that certain miRNAs showed many more 39/59
deletions than did others, suggesting that most of them likely
are genuine isomiRs. Similarly, although the SOLiD 2-base
system interrogates each base twice during the sequencing
process, we cannot rule out that sequencing errors occur.
Nevertheless, isoforms found at high levels may be accepted
with a good degree of confidence.
Given the importance of the seed region (nucleotides 2–8
from the 59) of the miRNA for recognition of the target
mRNA (Lewis et al. 2005; Bartel 2009), variations at the 59
end are particularly interesting: It has been suggested that
multiple mature miRNAs, descending from one miRNA
precursor, might have different seed sequences, thus recog-
nizing a different set of targets (Azuma-Mukai et al. 2008;
Chiang et al. 2010).
Interestingly, the annotated mature sequence was not
always the most abundant form: For 33 miRNAs species, an
isomiR variant was expressed at higher levels. For instance,
a longer miR-21 isomiR was seven times more abundant
than the form annotated in miRBase. By making use of the
miRBase deep-sequencing data, we found that for 16 of these
miRNAs, others had the same results. For the remaining 17,
the observed sequence was found as the most abundant in
endothelium only and may be possibly attributed to the cell
type of origin.
Finally, further studies are warranted to determine
whether stress stimuli such as hypoxia might affect miRNA
post-transcriptional regulation and the differential accu-
mulation of isomiRs (Fernandez-Valverde et al. 2010).
Strand selection seems to be based on the stability of 59
base-paired ends in the miRNA/miRNA* duplex (Winter
et al. 2009; Krol et al. 2010). However, much remains to be
discovered about this process. In contrast to the general
conception that miRNA* sequences are not functionally
active, recent studies revealed that the abundance, possible
function, and physiological relevance of miRNA*s have
been underestimated (Mah et al. 2010). Arm switching by
alternative strand selection seems to provide a fundamen-
tal mechanism to evolve the function of a miRNA locus
and target gene network (Ruby et al. 2007; de Wit et al.
2009; Griffiths-Jones et al. 2011). Moreover, strand selec-
tion is highly regulated since it shows tissue-, cell-, and
FIGURE 8. Novel-112 and novel-144 affect hypoxia-induced
growth arrest. HUVECs were transfected with novel-112 or novel-
144 mimics or with a control scramble sequence. The next day (T0),
cells were exposed to 1% hypoxia for the indicated time and
counted. Following hypoxia, novel-112 expression significantly de-
creased (A) and novel-144 expression significantly increased (B) cell
number compared with that of the control (n = 16; *P < 0.003;
***P < 0.0005).
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condition-specific modulation. Indeed, miRNA* species seem
to have an impact on gene expression and regulatory net-
works, suggesting their contribution to disease states (Ro et al.
2007; Chiang et al. 2010; Biasiolo et al. 2011; Yang et al. 2011).
In keeping with these observations, in endothelial cells
several annotated miRNA* forms were also much more
abundant than their mature miRNA siblings (miR-33a, -214,
and -616). This suggests that in endothelial cells, these an-
notated star sequences do not constitute the passenger
strand, fated to degradation, but rather the guide strand,
having regulatory activity. Further investigations are necessary
to verify these findings. Whether these miRNAs also display
alternative duplex strand selection in other cell types remains
to be determined. Furthermore, by detailed analysis of se-
quences mapping to both arms of annotated stem–loops, we
discovered nine novel, not yet annotated miRNA* sequences.
For the discovery of novel miRNAs, highly stringent
exclusion criteria based on the abundance, quality of align-
ment, and localization on the stem of predicted hairpins were
applied. By these means, 511 candidates for potential novel
miRNAs were identified.
Given the ongoing miRNA identification techniques, the
miRNAs discovered so far are expected to be the most
abundantly and ubiquitously expressed. Other frequently
used identification parameters include evolutionary con-
servation (Mendes et al. 2009; Yousef et al. 2009) and
clusterization with other miRNAs (Sewer et al. 2005). Thus,
we were not surprised that the average expression of miRNA
candidates was lower than that of annotated miRNAs.
However, several novel miRNAs displayed expression levels
similar to these of many annotated ones. Moreover, most
novel miRNAs displayed very low conservation among verte-
brates, with some exceptions, such as novel-53.
A recent article indicated that convincing evidence was
lacking about the ability of nearly one-third of the mouse
miRNA genes annotated in miRBase version 14.0 to
generate authentic miRNAs (Chiang et al. 2010). While
further studies are needed, we addressed the concern that
many nonconserved candidate miRNAs, often expressed
at low levels, could be sequencing artifacts or random
products of Drosha/Dicer processing instead of genuine
miRNAs. To this purpose, we selected 28 miRNA candi-
dates and assayed their levels by qPCR and found that 23
candidates were readily detectable. Thus, most small RNAs
were validated with an independent technique. Moreover,
the candidate miRNAs that we failed to detect are not
necessarily artifacts. Indeed, we did not troubleshoot the
custom qPCR assays extensively, and these tests may lack
the necessary sensitivity. For the same reason, we did not
further validate novel-735, since it is very similar to miR-
151 and we had no conclusive evidence of that our qPCR
assay could discriminate between these miRNA species,
likely belonging to the same family. Furthermore, two of
the newly identified miRNAs could be detected by Northern
blotting. Then, we speculated that association to the RISC is
the most stringent assay to determine whether a candidate
miRNA is indeed functional (Karginov et al. 2007; Fasanaro
et al. 2009). We found that 18 out of 22 candidate miRNAs
were indeed associated to RISC immunoprecipitates, and we
considered these as genuine novel miRNAs. It is highly likely
that additional novel miRNAs are present in the candidate
data set. However, this requires individual experimental testing.
Thus, we intend the candidate miRNAs data set to be a subset
of expressed RNAs highly enriched for miRNAs species.
To gain further insight into the possible biological
significance of newly identified and annotated miRNAs
modulated in hypoxic conditions, a pathway-based analyt-
ical tool was used (IPA). Targets predicted for novel-112,
novel-144, and miR-210 were analyzed for a significant
association to biological pathways and networks. Most in-
terestingly, IPA analysis revealed a significant association to
the hypoxia-inducible factor signaling pathway. Encourag-
ingly, a significant relation of 85 and 100 predicted target
genes to cardiovascular diseases and cancer, respectively,
were also identified. Indeed, in both these diseases, hypoxia
plays a critical pathogenetic role (Semenza 2010a,b). More-
over, novel-112, novel-144, and miR-210 predicted targets
were enriched among the hypoxia-modulated genes in
HUVECs exposed to hypoxia, further confirming the likely
biological relevance of the regulation of these miRNAs. In
keeping with this interpretation, overexpression of novel-112
and novel-144 in HUVECs under hypoxic conditions had
a significant impact on the endothelial cell growth.
CONCLUSIONS
In conclusion, deep-sequencing is confirmed as a valid
technological platform to investigate the complete reper-
toire of miRNA and miRNA variants expressed in vascular
cells. A first description of the miRNA population charac-
terizing human endothelial cells was delineated. It appears
clear that in spite of the close attention of the scientific
community in the past few years, the effort toward the
identification of human miRNAs is far from over. Many
new miRNA genes remain to be discovered, likely dis-
playing low conservation and cell lineage–restricted ex-
pression. In this study only, we report the discovery of 18
new miRNAs and nine miRNA* species and pave the way for
the discovery of many more. Furthermore, we also highlighted
the high degree of variability of the miRNAs expressed in
endothelial cells.
Hypoxia is a crucial pathogenetic component of ische-
mia characterizing very widespread diseases such as cancer,
myocardial infarction, stroke, and ischemic ulcers. We
think that this study may further improve our understand-
ing of the molecular mechanisms underpinning these
diseases. In this respect, further studies are needed to
explore whether the two novel miRNAs that we found to
be modulated by hypoxia in vitro are involved in tissue
response to ischemia.
microRNA sequencing of hypoxic endothelial cells
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MATERIALS AND METHODS
Cell culture
Primary HUVECs (Lonza) were grown in EGM-2 medium
(Lonza) containing 2% FBS. The human embryonic kidney 293
cell line (HEK-293, ATCC) was cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal bovine serum
(Fasanaro et al. 2008). HUVECs were kept under hypoxic condi-
tions (1% and 2% oxygen) using a hypoxic incubator (Forma Series
II 3110 Water Jacketed CO2 Incubator, Thermo Scientific) where
the O2 concentration is continuously monitored and adjusted to
the desired level by N2 injections (Fasanaro et al. 2008).
RNA purification and small RNA library generation
and sequencing
Total RNA was extracted using TRIzol (Invitrogen). For library
preparation, total RNA was extracted from two independent
sample pairs of HUVECs, exposed to 1% oxygen or normoxic
conditions for 24 h. In addition, total RNA of one sample pair was
further enriched for small RNAs up to 60 bp by size-selection
using a flashPAGE fractionator following the Ambion protocol
(Ambion). RNA purity, integrity, and size distribution were
assessed using an Agilent 2100 Bioanalyzer (Agilent Technolo-
gies). Then, four sequencing libraries were generated using the
Small RNA Expression Kit according to the manufacturer’s protocol
(SREK Rev. C, Applied Biosystems). Briefly, RNA was first hybrid-
ized and ligated with the adapter mix B and subsequently reverse
transcribed and treated with RNase H. The obtained cDNA libraries
were PCR amplified, purified, and size-selected by PAGE, resulting
in libraries containing inserted small RNA sequences of 20–40 bp in
length. Size, integrity, and purity of the libraries were verified by the
Agilent 2100 Bioanalyzer (Agilent Technologies). cDNA libraries
were amplified onto beads using emulsion PCR; templated beads
were deposited on slides and analyzed using the Applied Biosystems
SOLiD-3 Sequencer. The obtained sequence reads and correspond-
ing quality values were first filtered with an in-house generated perl
script in order to eliminate any read with one or more ‘‘noncalled’’
bases. The remaining sequences were then filtered for a minimal
quality value of 9 with the SOLiD Software Development Commu-
nity csfasta_quality_filter.pl script (http://solidsoftwaretools.com/gf/).
Since SOLiD reads (35 nt) were longer than the expected length of
mature miRNAs (20–23 nt), the miRNA reads apparently contained
part of the adapter sequence. To avoid high rates of sequencing
errors or mismatches due to the adapter, the reads were trimmed
to 25 nt in length after removing all reads that map to the genome
over larger intervals. The GEO accession number for this study is
GSE26497 and can be accessed at http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?token=rnkdxeuaiyquqdm&acc=GSE26497.
Annotated miRNA analysis and mapping
The quality filtered reads were mapped against all annotated
human mature and precursor miRNA sequences (miRBase ver-
sion 14.0) (Griffiths-Jones et al. 2008) using a specifically designed
set of SHRiMP-parameters (Rumble et al. 2009) for optimal
miRNA sequence detection, as displayed in Figure 9. All reads
were also mapped against a nonredundant compilation of other
small noncoding RNA sequences retrieved from GenBank (Benson
et al. 2009), RNAdb (version 2.0) (Pang et al. 2007), and NONCODE
(He et al. 2008), in addition to ribosomal RNA and transfer RNA
sequences downloaded from GenBank and coding and noncoding
RefSeq sequences from the UCSC corresponding to the hg19
assembly version. Any sequence mapping with a maximum one
mismatch in color space against one of these collections was
subsequently excluded from the miRNA alignment data sets in
order to avoid false-positive counts. The miRNA mappings were
passed through an alignment quality filter, requiring a minimum
alignment length of 17 nt between the read and reference, allowing
not more than one mismatch and not more than three sequencing
errors. Reads with sequencing errors in the first 15 nt were
excluded, and no mismatches were allowed in the seed region of
the miRNA. Finally, each read was assigned to its corresponding
miRNA, and the number of sequences detected per miRNA
(counts) were calculated. Then, the number of counts for each of
the miRBase annotated miRNAs was normalized by expressing
the counts in percentages of the total library size (percentage
counts). After applying an abundance threshold of 0.001% of
total counts per library, analysis of the expression levels and
mature sequence variations (isomiRs), together with identifica-
tion of novel miRNA star sequences, was carried out.
Discovery of novel miRNA* sequences
To identify novel miRNA* sequences, the output of the SHRiMP-
mapping versus human stem–loop sequences of miRBase was
screened for miRNAs with annotation only for the mature sequence,
harboring five or more reads mapping to an identical position on the
opposite arm in all four libraries and showing an average abundance
of at least 0.001% percentage counts. Subsequently, only the putative
novel star sequences lying within 63 nt opposite of, and sharing at
least 50% sequence complementarity with, their respective annotated
mature sequence were accepted as novel star candidates.
miRNA IsomiR analysis
For isomiR analysis (additions, deletions, and single-base varia-
tions in the annotated mature miRNA sequence), counts were
divided between the sequence variations identified for each mature
miRNA. IsomiRs with average percentage counts <0.001% were
removed, and corresponding statistical analyses were computed.
miRNA species showing a higher abundance for at least one isomiR
compared with the annotated sequence were analyzed singularly
FIGURE 9. SHRiMP mask. Illustration of the set of masks (5 3 20
bases) used for local alignment of the reads against the human miRBase
and the human genome by SHRiMP. The symbol 1 indicates positions
that must be identical to the corresponding nucleotide in the reference
sequence, while the symbol 0 indicates positions that may mismatch
(with a penalty to final score). Only reads with perfect alignment of the
seed region (location 3–8) and with a maximum of two mismatches in
the following bases at any position (location 9–18) were accepted. At
the first and last two positions, mismatches were allowed to identify
also miRNA length variants. Further selection criteria were adopted at
later analysis stages.
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and mapped against the human genome using BLAT (Kent 2002)
to confirm genomic alignment.
Alternative arm selection of annotated
miRNA/miRNA* pairs
The ratios of the miRNA/miRNA* species percentage counts were
calculated. Any annotated miRNA* sequence with at least 0.001
percentage counts (averaged over all four libraries) and at least
a five times higher expression level compared with the relevant
mature sequence was further investigated.
Small RNA genomic mapping
Small RNA SOLiD sequences were mapped against the human
hg19 genome sequences with parallel instances of SHRiMP
(Rumble et al. 2009), with the same original parameter set used
in the annotated miRNAs (see Fig. 9). After filtering the sequences
that mapped against the human genome for alignment quality
(minimum alignment of 19 nt and only one mismatch/sequencing
error allowed), all reads mapping to the genome coordinates cor-
responding to any annotated small noncoding RNA comprised in
miRBase (Griffiths-Jones et al. 2008), GenBank (Benson et al.
2009), RNAdb (version 2.0) (Pang et al. 2007) or NONCODE (He
et al. 2008) were excluded. Additionally, reads mapping more than
three times to the human genome (nonspecific) or overlapping
with simple repeats (http://hgdownload.cse.ucsc.edu/goldenPath/
hg18/database/) were removed from the data set. Subsequently, all
reads with alignments starting at an identical 59 position were
merged, and the genomic positions harboring 100 or more counts
in at least one of the four libraries were retrieved. Finally, these
coordinates were intersected with a custom database containing
genome-wide short RNA hairpin structure predictions. Predictions
of plausible miRNA precursor-like structures were made by scanning
across the entire human genome, including repetitive regions.
RNALfold and a perl script were used to identify miRNA pre-
cursor-like structures, using a sliding window size of 110 nt, which
allows a maximum stem length of z45–50 nt. Predicted single
unbranched stems were selected with folding energies of 30kcal/
mol or better, terminal loops #20 nt, and bulges <5 nt on one side
of the stem. We identified 2,443,320 pre-miRNA–like structures, of
which 1,564,161 did not contain repetitive SINE elements. This set
predicts 71% of known human miRNAs (miRBase version 9.0)
(Griffiths-Jones et al. 2006). In the UCSC browser, most predictions
are located in introns and intergenic sequences, with the prediction
set showing enrichment for 59 UTRs, knownGene exons, and splice
sites, which may be a consequence of the higher GC content of
these regions. Afterward, only the genomic locations positioned on
the stem of a predicted hairpin (not in a side bulge or loop) were
accepted for further analysis. Reads identified as mature human
miRNA species during the miRBase mapping were used as
positive controls by running them through the same pipeline.
To exclude reads aligning >25 nt, results of genome mappings
obtained with the alignment tool Bowtie (Langmead et al. 2009)
were used to intersect the reads of normoxic and hypoxic library
2, now trimmed to three different lengths (i.e., 23, 28, and 33 nt)
with the coordinates of the predicted precursors. Candidate precursors
overlapping with reads aligning for >23 nt were excluded if the counts
of these aligned reads trimmed to 28 and/or 33 nt in any of the two
libraries represented >5% of the counts of the 23-nt trimmed reads.
An essential requirement for a genuine mature miRNA is the
consistent processing of its 59 end. For the identification of short
RNA sequences due to degradation processes, the flanking regions of
the putative 59 end of all candidates were investigated. According to
criteria described before (Chiang et al. 2010), we determined the total
number of reads mapping within 630 nt from the candidate 59 end.
Candidates were excluded if <50% of all reads mapping within the
investigated region were present within62 nt or if <50% of the reads
within the region of 62 nt were mapping to the precise 59 end.
Each candidate miRNA, translated in sequence space from color
space, was mapped against human genome (hg19, UCSC) using
BLAT (Kent 2002) to confirm genomic location and aligned against
the fRNAdb (Pang et al. 2007) and miRBase (version 18.0) (Griffiths-
Jones et al. 2008) to confirm their absence in these data sets.
Comparison of deep-sequencing with other miRNA
profiling techniques
Annotated miRNA data obtained by deep-sequencing were com-
pared to HUVEC profiles obtained with different techniques. For this
purpose, the averaged, Log10 transformed counts of the miRNAs
expressed by the two normoxic HUVEC populations were compared
with the profiles previously obtained by either qPCR or microarrays
in independent HUVEC populations. In this deep-sequencing data
analysis, miRNAs were considered as expressed if at least one read
was measured in each normoxic HUVEC library. For qPCR/deep-
sequencing comparison, 159 miRNA/miRNAs* were tested in four
different HUVEC samples by TaqMan qPCR (Fasanaro et al. 2008).
For this analysis, only miRNAs showing average Ct values <38 were
used. After normality assessment using the Kolmogorov-Smirnov
test, Pearson correlation was calculated for 114 miRNA species. For
array/deep-sequencing analysis, seven independent miRNA profiles
were obtained using the miRCURY LNA microRNA Array version
11.0 (Exiqon) platform. Average Log10 transformed Hy3 intensities
of the miRNAs displaying signal to noise ratio >3 were used. After
normality assessment using the Kolmogorov-Smirnov test, Spear-
mann correlation was calculated for 269 miRNA/miRNA* species.
qPCR
Annotated and candidate miRNAs were assayed by real-time
reverse transcriptase (RT) qPCR using the miScript PCR System
(Qiagen) according to the manufacturer’s protocols. Total
RNAs (25 ng) of the HUVECs were first reverse transcribed
and then amplified by SYBR Green PCR, using the miScript
Universal Primer and the miRNA-specific forward primer,
custom-designed for the newly discovered sequences. When
applicable, data were normalized to hsa-miR-16 levels, and the
relative expression was calculated using the comparative Ct method
(2–DDCt) (Livak and Schmittgen 2001). Reactions run without either
RT or the template were used as negative controls. Amplification
reactions were performed using the 7900HT Fast Real-Time PCR
System (Applied Biosystems), and a melting curve analysis was
carried out to verify specificity of the amplification products.
RNA/RISC coimmunoprecipitation
HEK-293 cells were transfected with either an expression vector
for c-Myc-Ago2 (Karginov et al. 2007) or vector alone using
Fugene 6 (Roche) according to the manufacturer instructions.
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RISC immunoprecipitation was performed as previously de-
scribed (Fasanaro et al. 2009). Briefly, transfected cells were
harvested in 1 mL/p15 dish of cold lysis buffer (25 mmol/L Tris-
HCl at pH 7.4, 150 mmol/L KCl, 0.5% ½w/v NP40, 5 mmol/L
EDTA) supplemented with 5 mmol/L dithiothreitol, protease
inhibitors mixture tablets (Roche), 1 mmol/L phenylmethylsul-
fonyl fluoride, and 100 units/mL of RNasin Plus (Promega).
After 30 min at 4°C, samples were precleared for 10 min with 75
mL/mL of A/G-agarose beads (Santa Cruz) and spun at 4°C at
20.000g in a microcentrifuge for 30 min. Next, lysates were
incubated with 2.5 mg/mL of anti-c-myc antibody (9E10, Santa
Cruz) for 3 h at 4°C, and then 50 mL/mL of A/G-agarose beads
were added to each sample. After 1 h, immunocomplexes were
washed twice with lysis buffer and resuspended in 200 mL
of TRIzol (Invitrogen). RNA was purified, and miRNAs were
measured by qPCR. The enrichment of candidate and annotated
miRNAs was determined by calculating the DCT between immu-
noprecipitates derived from c-Myc-Ago2–transfected HEK-293 cells
and their respective controls.
miRNA overexpression and growth curves
Customer-designed miScript miRNA mimics (Qiagen) or nega-
tive control siRNA sequence (Qiagen) were transfected by small,
interfering RNA transfection reagent (Santa Cruz Biotechnology) in
40% confluent HUVECs (4 3 103/cm2) at the final concentration
of 40 nM. After 16 h, cells were incubated with fresh medium for 4
h and exposed to 1% oxygen for 24 and 48 h. The cell number was
measured by the Countess cell counter (Invitrogen).
Northern blot
Total RNA was separated on a 15% polyacrylamide/7 M urea gel
(10 mg/lane) by electrophoresis and transferred onto Amersham
Hybond-N+ membrane (GE Healthcare) by electroblotting. Cus-
tomer-designed miRCURY probes (Locked Nucleic Acid oligonu-
cleotides, Exiqon) for novel-181 and novel-1322 were terminally
labeled with g-32P-ATP, and hybridization was performed overnight
at 55°C, as previously described (Fasanaro et al. 2008). MicroRNA
Marker (New England BioLabs) was used as a size marker.
Target prediction and pathway analysis
Bioinformatic prediction of target gene sites for miRNAs signif-
icantly modulated by hypoxia (novel-112, novel-144, and hsa-
miR-210) was performed using TargetScan Human 5.1 (Lewis
et al. 2005) and DIANA-microT version 3.0 (Maragkakis et al.
2009); experimentally confirmed targets of miR-210 were also
included (Devlin et al. 2011). Enriched pathways among miRNA
targets were generated by Ingenuity Pathways Analysis (version 8.8,
Ingenuity Systems), using the Ingenuity Pathways Knowledge Base as
reference set and assuming direct and indirect relationships. Fischer’s
exact test was used for statistical analysis and a P-value #0.05 was
considered significant.
The targets predicted for novel-112, novel-144, and hsa-miR-210
were intersected with mRNA expression data derived from HUVECs
exposed to hypoxia conditions identical to these adopted in our study
(P Fasanaro and F Martelli, unpubl.). Genes displaying a significant
(P < 0.01) expression difference between normoxic and hypoxic cells
were identified by the class comparison function of BRB-ArrayTools
software (version 4.1.0, Beta_3 Release, October 2010). These genes
were then intersected with the computationally predicted miRNA
targets, and only opposite modulated miRNA/mRNA couples were
considered. Significance of predicted target-gene enrichment for
novel-112, novel-144 and hsa-miR-210, was calculated with a x2 test.
Statistical analysis
Variables were analyzed by two-tailed Student t-test unless in-
dicated differently, using GraphPad Prism version 4.00 (GraphPad
Software). A value of P # 0.05 was deemed statistically significant.
Results are reported as mean 6 SE.
DATA DEPOSITION
The identified 18 novel miRNAs were submitted to miRBase and the








Furthermore, the nine novel miRNA* species will be added to
miRBase as: hsa-miR-216a-3p, hsa-miR-376a-2-5p, hsa-miR-
376b-5p, hsa-miR-376c-5p, hsa-miR-381-5p, hsa-miR-495-5p,
hsa-miR-503-3p, hsa-miR-758-5p, hsa-miR-98-3p.
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Supplemental material is available for this article.
ACKNOWLEDGMENTS
This work was partly supported by the Ministero della Salute
(Italian Ministry of Public Health, RF07Onc-26/1, RC11, RFS07).
Received March 30, 2011; accepted December 7, 2011.
REFERENCES
Audic S, Claverie JM. 1997. The significance of digital gene expression
profiles. Genome Res 7: 986–995.
Azuma-Mukai A, Oguri H, Mituyama T, Qian ZR, Asai K, Siomi H,
Siomi MC. 2008. Characterization of endogenous human Argo-
nautes and their miRNA partners in RNA silencing. Proc Natl Acad
Sci 105: 7964–7969.
Bartel DP. 2009. MicroRNAs: target recognition and regulatory
functions. Cell 136: 215–233.
Benes V, Castoldi M. 2010. Expression profiling of microRNA using
real-time quantitative PCR, how to use it and what is available.
Methods 50: 244–249.
Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. 2009.
GenBank. Nucleic Acids Res 37: D26–D31.
Biasiolo M, Sales G, Lionetti M, Agnelli L, Todoerti K, Bisognin A,
Coppe A, Romualdi C, Neri A, Bortoluzzi S. 2011. Impact of
host genes and strand selection on miRNA and miRNA*
expression. PLoS ONE 6: e23854. doi: 10.1371/journal.pone.
0023854.
Voellenkle et al.
482 RNA, Vol. 18, No. 3
 Cold Spring Harbor Laboratory Press on December 9, 2015 - Published by rnajournal.cshlp.orgDownloaded from 
Brameier M, Herwig A, Reinhardt R, Walter L, Gruber J. 2011.
Human box C/D snoRNAs with miRNA like functions: expanding
the range of regulatory RNAs. Nucleic Acids Res 39: 675–686.
Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo
J. 2009. MicroRNA-210 controls mitochondrial metabolism dur-
ing hypoxia by repressing the iron-sulfur cluster assembly proteins
ISCU1/2. Cell Metab 10: 273–284.
Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, Baek D,
Johnston WK, Russ C, Luo S, Babiarz JE, et al. 2010. Mammalian
microRNAs: experimental evaluation of novel and previously
annotated genes. Genes Dev 24: 992–1009.
de Wit E, Linsen SE, Cuppen E, Berezikov E. 2009. Repertoire and
evolution of miRNA genes in four divergent nematode species.
Genome Res 19: 2064–2074.
Devlin C, Greco S, Martelli F, Ivan M. 2011. miR-210: More than
a silent player in hypoxia. IUBMB Life 63: 94–100.
Dorn GW 2nd. 2010. Therapeutic potential of microRNAs in heart
failure. Curr Cardiol Rep 12: 209–215.
Dupuis DE, Maas S. 2010. MiRNA editing. Methods Mol Biol 667:
267–279.
Ender C, Krek A, Friedlander MR, Beitzinger M, Weinmann L, Chen
W, Pfeffer S, Rajewsky N, Meister G. 2008. A human snoRNA with
microRNA-like functions. Mol Cell 32: 519–528.
Fasanaro P, D’Alessandra Y, Di Stefano V, Melchionna R, Romani S,
Pompilio G, Capogrossi MC, Martelli F. 2008. MicroRNA-210
modulates endothelial cell response to hypoxia and inhibits the
receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283:
15878–15883.
Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, Kulshreshtha
R, Banfi C, Stubbs A, Calin GA, Ivan M, et al. 2009. An integrated
approach for experimental target identification of hypoxia-induced
miR-210. J Biol Chem 284: 35134–35143.
Fasanaro P, Greco S, Ivan M, Capogrossi MC, Martelli F. 2010.
microRNA: emerging therapeutic targets in acute ischemic dis-
eases. Pharmacol Ther 125: 92–104.
Fernandez-Valverde SL, Taft RJ, Mattick JS. 2010. Dynamic isomiR
regulation in Drosophila development. RNA 16: 1881–1888.
Garzon R, Calin GA, Croce CM. 2009. MicroRNAs in cancer. Annu
Rev Med 60: 167–179.
Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ.
2006. miRBase: microRNA sequences, targets and gene nomen-
clature. Nucleic Acids Res 34: D140–D144.
Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. 2008. miRBase:
tools for microRNA genomics. Nucleic Acids Res 36: D154–D158.
Griffiths-Jones S, Hui JH, Marco A, Ronshaugen M. 2011. MicroRNA
evolution by arm switching. EMBO Rep 12: 172–177.
He S, Liu C, Skogerbo G, Zhao H, Wang J, Liu T, Bai B, Zhao Y, Chen
R. 2008. NONCODE v2.0: decoding the non-coding. Nucleic Acids
Res 36: D170–D172.
Ivan M, Harris AL, Martelli F, Kulshreshtha R. 2008. Hypoxia
response and microRNAs: no longer two separate worlds. J Cell
Mol Med 12: 1426–1431.
Karginov FV, Conaco C, Xuan Z, Schmidt BH, Parker JS, Mandel G,
Hannon GJ. 2007. A biochemical approach to identifying micro-
RNA targets. Proc Natl Acad Sci 104: 19291–19296.
Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura
K. 2007. RNA editing of the microRNA-151 precursor blocks
cleavage by the Dicer-TRBP complex. EMBO Rep 8: 763–769.
Kawaji H, Nakamura M, Takahashi Y, Sandelin A, Katayama S,
Fukuda S, Daub CO, Kai C, Kawai J, Yasuda J, et al. 2008. Hidden
layers of human small RNAs. BMC Genomics 9: 157. doi: 10.1186/
1471-2164-9-157.
Kent WJ. 2002. BLAT—the BLAST-like alignment tool. Genome Res
12: 656–664.
Krol J, Loedige I, Filipowicz W. 2010. The widespread regulation of
microRNA biogenesis, function and decay. Nat Rev Genet 11: 597–
610.
Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer
S, Rice A, Kamphorst AO, Landthaler M, et al. 2007. A mamma-
lian microRNA expression atlas based on small RNA library
sequencing. Cell 129: 1401–1414.
Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and
memory-efficient alignment of short DNA sequences to the human
genome. Genome Biol 10: R25. doi: 10.1186/gb-2009-10-3-r25.
Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often
flanked by adenosines, indicates that thousands of human genes
are microRNA targets. Cell 120: 15–20.
Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression
data using real-time quantitative PCR and the 2DDCT method.
Methods 25: 402–408.
Mah S, Buske C, Humphries R, Kuchenbauer F. 2010. miRNA*: A
passenger stranded in RNA-induced silencing complex? Crit Rev
Eukaryot Gene Expr 20: 141–148.
Maragkakis M, Reczko M, Simossis VA, Alexiou P, Papadopoulos GL,
Dalamagas T, Giannopoulos G, Goumas G, Koukis E, Kourtis K, et al.
2009. DIANA-microT web server: elucidating microRNA functions
through target prediction. Nucleic Acids Res 37: W273–W276.
Marti E, Pantano L, Banez-Coronel M, Llorens F, Minones-Moyano
E, Porta S, Sumoy L, Ferrer I, Estivill X. 2010. A myriad of miRNA
variants in control and Huntington’s disease brain regions
detected by massively parallel sequencing. Nucleic Acids Res 38:
7219–7235.
Matkovich SJ, Zhang Y, Van Booven DJ, Dorn GW 2nd. 2010. Deep
mRNA sequencing for in vivo functional analysis of cardiac
transcriptional regulators: application to Gaq. Circ Res 106: 1459–
1467.
McCormick R, Buffa FM, Ragoussis J, Harris AL. 2010. The role of
hypoxia regulated microRNAs in cancer. Curr Top Microbiol
Immunol 345: 47–70.
Mendes ND, Freitas AT, Sagot MF. 2009. Current tools for the
identification of miRNA genes and their targets. Nucleic Acids Res
37: 2419–2433.
Morin RD, O’Connor MD, Griffith M, Kuchenbauer F, Delaney A,
Prabhu AL, Zhao Y, McDonald H, Zeng T, Hirst M, et al. 2008.
Application of massively parallel sequencing to microRNA pro-
filing and discovery in human embryonic stem cells. Genome Res
18: 610–621.
Ono M, Scott MS, Yamada K, Avolio F, Barton GJ, Lamond AI. 2011.
Identification of human miRNA precursors that resemble box C/D
snoRNAs. Nucleic Acids Res 39: 3879–3891.
Pang KC, Stephen S, Dinger ME, Engstrom PG, Lenhard B, Mattick
JS. 2007. RNAdb 2.0–an expanded database of mammalian non-
coding RNAs. Nucleic Acids Res 35: D178–D182.
Ro S, Park C, Young D, Sanders KM, Yan W. 2007. Tissue-
dependent paired expression of miRNAs. Nucleic Acids Res 35:
5944–5953.
Ruby JG, Stark A, Johnston WK, Kellis M, Bartel DP, Lai EC. 2007.
Evolution, biogenesis, expression, and target predictions of a sub-
stantially expanded set of Drosophila microRNAs. Genome Res 17:
1850–1864.
Rumble SM, Lacroute P, Dalca AV, Fiume M, Sidow A, Brudno M.
2009. SHRiMP: accurate mapping of short color-space reads. PLoS
Comput Biol 5: e1000386. doi: 10.1371/journal.pcbi.1000386.
Schulte JH, Marschall T, Martin M, Rosenstiel P, Mestdagh P, Schlierf
S, Thor T, Vandesompele J, Eggert A, Schreiber S, et al. 2010. Deep
sequencing reveals differential expression of microRNAs in favor-
able versus unfavorable neuroblastoma. Nucleic Acids Res 38: 5919–
5928.
Semenza GL. 2010a. Defining the role of hypoxia-inducible factor 1 in
cancer biology and therapeutics. Oncogene 29: 625–634.
Semenza GL. 2010b. Vascular responses to hypoxia and ischemia.
Arterioscler Thromb Vasc Biol 30: 648–652.
Sewer A, Paul N, Landgraf P, Aravin A, Pfeffer S, Brownstein MJ,
Tuschl T, van Nimwegen E, Zavolan M. 2005. Identification of
clustered microRNAs using an ab initio prediction method. BMC
Bioinformatics 6: 267. doi: 10.1186/1471-2105-6-267.
Shendure J. 2008. The beginning of the end for microarrays? Nat
Methods 5: 585–587.
microRNA sequencing of hypoxic endothelial cells
www.rnajournal.org 483
 Cold Spring Harbor Laboratory Press on December 9, 2015 - Published by rnajournal.cshlp.orgDownloaded from 
Urbich C, Kuehbacher A, Dimmeler S. 2008. Role of microRNAs in vascular
diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581–588.
Winter J, Jung S, Keller S, Gregory RI, Diederichs S. 2009. Many roads
to maturity: microRNA biogenesis pathways and their regulation.
Nat Cell Biol 11: 228–234.
Wu H, Ye C, Ramirez D, Manjunath N. 2009. Alternative processing
of primary microRNA transcripts by Drosha generates 59 end
variation of mature microRNA. PLoS ONE 4: e7566. doi: 10.1371/
journal.pone.0007566.
Yang JH, Shao P, Zhou H, Chen YQ, Qu LH. 2010. deepBase:
a database for deeply annotating and mining deep sequencing
data. Nucleic Acids Res 38: D123–D130.
Yang JS, Phillips MD, Betel D, Mu P, Ventura A, Siepel AC, Chen KC,
Lai EC. 2011. Widespread regulatory activity of vertebrate micro-
RNA* species. RNA 17: 312–326.
Yousef M, Showe L, Showe M. 2009. A study of microRNAs in silico
and in vivo: bioinformatics approaches to microRNA discovery
and target identification. FEBS J 276: 2150–2156.
Voellenkle et al.
484 RNA, Vol. 18, No. 3
 Cold Spring Harbor Laboratory Press on December 9, 2015 - Published by rnajournal.cshlp.orgDownloaded from 
 10.1261/rna.027615.111Access the most recent version at doi:
 2012 18: 472-484 originally published online January 26, 2012RNA
  
Christine Voellenkle, Jeroen van Rooij, Alessandro Guffanti, et al. 
  
complexity of known and novel microRNAs














 click here.right corner of the article or 
Receive free email alerts when new articles cite this article - sign up in the box at the top
 http://rnajournal.cshlp.org/subscriptions
 go to: RNATo subscribe to 
 Cold Spring Harbor Laboratory Press on December 9, 2015 - Published by rnajournal.cshlp.orgDownloaded from 
